Israel stocks ease; Teva loses patent ruling - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Israeli stocks rise; Brainsway, Ratio Oil off - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Mylan tries to fend off Teva with bigger bid for Perrigo - MarketWatch
There's scant evidence so far for chloroquine as a COVID-19 drug — but there's already a shortage - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva Pharmaceutical TEVA Pivots Trading Plans and Risk Controls - MarketWatch
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva Pharmaceuticals - Wikipedia
Israel stocks lower; Ness agrees to takeover - MarketWatch
Scum of the earth': Opioid victims unload on Purdue Pharma owners - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Latest twist in pharma love triangle as Teva pursues Mylan merger - MarketWatch
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
Teva Poised to Get a Big Boost in Generics - WSJ
Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes - MarketWatch
Teva's generic EpiPen approved in the U.S., with perfect timing - MarketWatch
Drug stocks move higher in late trading - MarketWatch
